Literature DB >> 16148471

Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups.

Hendrik Schmidt1, Ursula Müller-Werdan, Thomas Hoffmann, Darrel P Francis, Massimo F Piepoli, Mathias Rauchhaus, Roland Prondzinsky, Harald Loppnow, Michael Buerke, Dirk Hoyer, Karl Werdan.   

Abstract

OBJECTIVE: Multiple organ dysfunction syndrome (MODS) is the sequential failure of several organ systems after a trigger event, like sepsis or cardiogenic shock. Mortality rate is high, up to 70%. Autonomic dysfunction may substantially contribute to the development of MODS. Our study aimed to characterize a) the spectrum of autonomic dysfunction of critically ill MODS patients; b) whether autonomic dysfunction is different in patients receiving sedation, mechanical ventilation, or catecholamines; c) the age dependency of autonomic dysfunction in MODS; and d) whether autonomic dysfunction predicts mortality in MODS.
DESIGN: Prospective cohort study.
SETTING: Twelve-bed medical intensive care unit in a university center. PATIENTS: Ninety consecutively admitted score-defined MODS patients.
INTERVENTIONS: Assessment of heart rate variability, baroreflex sensitivity, and chemoreflex sensitivity as markers of autonomic dysfunction. The patients were followed for 28-day mortality.
MEASUREMENTS AND MAIN RESULTS: Baroreflex sensitivity, chemoreflex sensitivity, and almost all indexes of heart rate variability were attenuated in comparison to normal range data. There was no association between the assessed heart rate variability variables, baroreflex sensitivity or chemoreflex sensitivity, and the presence of sedation or catecholamine therapy. Except for frequency-domain variables, pNN50 (percentage of differences of successive RR intervals differing >50 msecs) and rMSSD (root mean square of successive difference of N-N intervals), none of the measured variables were related to the presence of mechanical ventilation. Age dependency was detected for baroreflex sensitivity but not for heart rate variability indexes or chemoreflex sensitivity (across ages 24-96 yrs). lnVLF predicted 28-day mortality best in the entire cohort of patients and in a subgroup of patients with cardiogenic-triggered MODS.
CONCLUSIONS: Autonomic function of MODS patients is blunted, and this attenuation has prognostic implications. The extensive influence of MODS on autonomic function overwhelms and masks the well-known age dependency of autonomic function seen in healthy persons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148471     DOI: 10.1097/01.ccm.0000178181.91250.99

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  82 in total

1.  Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.

Authors:  Sebastian Nuding; Henning Ebelt; Robert S Hoke; Annette Krummenerl; Andreas Wienke; Ursula Müller-Werdan; Karl Werdan
Journal:  Clin Res Cardiol       Date:  2011-06-03       Impact factor: 5.460

2.  Hydrocortisone at stress-associated concentrations helps maintain human heart rate variability during subsequent endotoxin challenge.

Authors:  Athos J Rassias; Paul M Guyre; Mark P Yeager
Journal:  J Crit Care       Date:  2011-04-21       Impact factor: 3.425

3.  Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.

Authors:  Robert S Hoke; Ursula Müller-Werdan; Christine Lautenschläger; Karl Werdan; Henning Ebelt
Journal:  Clin Res Cardiol       Date:  2011-11-03       Impact factor: 5.460

4.  [Sepsis and heart].

Authors:  H Ebelt; K Werdan
Journal:  Internist (Berl)       Date:  2010-07       Impact factor: 0.743

Review 5.  Rethinking inflammation: neural circuits in the regulation of immunity.

Authors:  Peder S Olofsson; Mauricio Rosas-Ballina; Yaakov A Levine; Kevin J Tracey
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 6.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 7.  Inflammation and ageing.

Authors:  U Müller-Werdan
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

8.  Autonomic regulation during mild therapeutic hypothermia in cardiopulmonary resuscitated patients.

Authors:  R Pfeifer; J Hopfe; C Ehrhardt; M Goernig; H R Figulla; A Voss
Journal:  Clin Res Cardiol       Date:  2011-04-08       Impact factor: 5.460

Review 9.  Integrated Cardio-Respiratory Control: Insight in Diabetes.

Authors:  Luciano Bernardi; Lucio Bianchi
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

10.  Positive end-expiratory pressure may alter breathing cardiovascular variability and baroreflex gain in mechanically ventilated patients.

Authors:  Andry Van de Louw; Claire Médigue; Yves Papelier; François Cottin
Journal:  Respir Res       Date:  2010-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.